Evolent Health Inc reports results for the quarter ended in September - Earnings Summary

Evolent Health

03/11/2023 02:13

* Evolent Health Inc  EVH.N  reported quarterly adjusted
earnings
of 30 cents​​ per share for the quarter ended in September,
lower than the same quarter last year, when the company reported
EPS of 59 cents.  The mean expectation of eleven analysts for
the quarter was for earnings of 7 cents per share. Wall Street
expected results to range from -14 cents to 16 cents per share.
    * Revenue rose 44.9% to $511.02 million from a year ago;
analysts
expected $509.24 million. 
    * Evolent Health Inc's reported EPS for the quarter was a
loss
of 30 cents​.
    * The company reported a quarterly loss of $33.2 million.
    * Evolent Health Inc shares had fallen by 11.8% this
quarter and
lost 14.5% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 4.4%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "buy"

Wall Street's median 12-month price target for Evolent Health
Inc is $46.00 
This summary was machine generated from LSEG data November 3 at
02:13 a.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2023      0.07           0.30           Beat
 Jun. 30 2023      0.11           0.14           Beat
 Mar. 31 2023      0.20           0.21           Beat
 Dec. 31 2022      0.16           0.10           Missed